Home›Clinical trials›Strength Training Response of Muscle in GLP-1 Users

A study listed on ClinicalTrials.gov.

Recruiting now. Registry record last updated January 21, 2026.

Who can join
Adults 50+.
What you take
Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts
The full study runs about 2 years.
What you get
Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.
Check my fit →
Phase Not ApplicableSponsor Virginia Polytechnic Institute and State UniversityDrug investigational drugClass OtherSites 1 USEnrollment target 30

What this study is for

Primary condition: Muscle Mass.

Full scientific study title: Strength Training Response of Muscle in GLP-1 Users.

Who can join

Age50 and upSexAny

Adults 50+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

  • Age, 50y+
  • Be taking GLP-1 medicine (Weygovy or Zepbound) for 1 month or less
  • Weight \<300 lb
  • Pass a health and exercise readiness screening

Key exclusion criteria

  • Age \<50
  • Weight \>300 lb
  • Osteoporosis
  • Active metabolic, neoplastic, or cardiovascular disease
  • Unable or unwilling to provide consent

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Virginia1 site
  • Virginia Tech
    Blacksburg, Virginia

Timeline

Started enrolling: October 8, 2025. Expected completion: May 2027. Last updated on ClinicalTrials.gov: January 21, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, editor of GLP Chart
John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this siteLinkedInContact
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.